Category > Discover Digital Health Startups in Drug Discovery

Discover Digital Health Startups in Drug Discovery

As of February 2025, the Drug Discovery category has a total of 304 Digital Health firms. The total venture volume has expanded at a CAGR of 5.5% over the past 5 years. The ventures have an average venture maturity score of 54.7.

From a funding perspective, these Digital Health companies have successfully raised $16.37B in venture capital investments, channeled through 740 distinct funding rounds. In the past 12 months, total venture capital funding closed at $3.58B across 76 deals.

Last Updated: February 14, 2026

Ventures

Venture	Primary Category	Country	Therapeutic Focus	Valuation	Stage	Current Funding
SandboxAQ	Drug Discovery	United States	xyrsttzsas	$ 123.46 B	Series E	$ 150.00 M
Valo Health	Drug Discovery	United States	xyrsttzsas	$ 123.46 B	Strategic	$ 190.00 M
BPGbio	Drug Discovery	United States	xyrsttzsas	$ 123.46 B	Private Equity	$ 480.00 M
Formation Bio	Drug Discovery	United States	xyrsttzsas	$ 123.46 B	Series D	$ 372.00 M
Standigm (스탠다임)	Drug Discovery	South Korea	xyrsttzsas	$ 123.46 B	Series D1	$ 9.73 M
Alentis Therapeutics	Drug Discovery	Switzerland	xyrsttzsas	$ 123.46 B	Series D	$ 181.40 M
Elemental Machines	Drug Discovery	United States	xyrsttzsas	$ 123.46 B	Series B	$ 41.00 M
BenchSci	Drug Discovery	Canada	xyrsttzsas	$ 123.46 B	Series D	$ 69.77 M
PharmCADD (팜캐드)	Drug Discovery	South Korea	xyrsttzsas	$ 123.46 B	Series B	$ 15.51 M
Verge Genomics	Drug Discovery	United States	xyrsttzsas	$ 123.46 B	Strategic	$ 42.00 M

Showing 1 to 10 of 327 entries